Bell J Simon, Rosen Alan, Aslani Parisa, Whitehead Paula, Chen Timothy F
Faculty of Pharmacy, The University of Sydney, New South Wales 2006, Australia.
Res Social Adm Pharm. 2007 Dec;3(4):392-409. doi: 10.1016/j.sapharm.2006.10.005.
People living with bipolar mood disorder and psychotic illnesses in Australia primarily access public-sector mental health care through community mental health teams (CMHTs). Adverse drug events are common among clients of CMHTs taking psychotropic medications.
The study aimed to investigate and describe a potential role for pharmacists as members of CMHTs.
Five study pharmacists were employed 1 day per week to work with 5 mental health teams over a 24-week period. The pharmacists conducted both client and team specific activities designed to optimize the use of medications. The pharmacists recorded their professional activities in diaries. Audiotaped focus groups were conducted with the pharmacists (n=1) and mental health team staff (n=3) at the conclusion of the study. Pharmacists' diaries and the transcripts of focus groups were thematically content analyzed.
Study pharmacists were perceived as valuable sources of unbiased and evidence-based drug information for both mental health team staff and their clients and caregivers. Mental health team staff particularly appreciated the provision of information about nonpsychotropic medications. Pharmacists' participation in clinical team meetings was used as an opportunity to present medication review findings and recommendations. Liaising between medication prescribers and dispensers working in primary and secondary care settings was deemed an important additional role; however, participating only 1 day per week was considered to delay rapport building and the establishment of collaborative working relationships with mental health team staff.
Including pharmacists as members of CMHTs addressed an unmet need for pharmaceutical services among clients and staff of CMHTs. Pharmacists' contributions were welcomed by mental health team staff. The study raised the issue of whether pharmacists should be considered as essential and legitimate members of interdisciplinary CMHTs.
在澳大利亚,患有双相情感障碍和精神病性疾病的人主要通过社区精神卫生团队(CMHTs)获得公共部门的精神卫生保健服务。在服用精神药物的CMHTs客户中,药物不良事件很常见。
本研究旨在调查和描述药剂师作为CMHTs成员的潜在作用。
五名参与研究的药剂师每周工作一天,在24周的时间里与五个精神卫生团队合作。药剂师开展了针对客户和团队的特定活动,旨在优化药物使用。药剂师在日记中记录了他们的专业活动。在研究结束时,对药剂师(n = 1)和精神卫生团队工作人员(n = 3)进行了录音焦点小组访谈。对药剂师的日记和焦点小组访谈记录进行了主题内容分析。
研究中的药剂师被视为精神卫生团队工作人员及其客户和护理人员获取无偏见且基于证据的药物信息的宝贵来源。精神卫生团队工作人员特别赞赏提供有关非精神药物的信息。药剂师参与临床团队会议被用作展示药物审查结果和建议的机会。在初级和二级护理环境中,联络药物开处方者和配药者之间的工作被视为一项重要的额外职责;然而,每周仅工作一天被认为会延迟与精神卫生团队工作人员建立融洽关系和合作工作关系。
将药剂师纳入CMHTs成员解决了CMHTs客户和工作人员对药学服务未满足的需求。精神卫生团队工作人员欢迎药剂师的贡献。该研究提出了药剂师是否应被视为跨学科CMHTs的重要且合法成员的问题。